Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Small Cell × Etoposide × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 136 Lymphoma, Large B-Cell, Diffuse 101 Lymphoma, Non-Hodgkin 97 Precursor Cell Lymphoblastic Leukemia-Lymphoma 95 Leukemia 78 Hodgkin Disease 77 Small Cell Lung Carcinoma 68 Leukemia, Myeloid, Acute 66 Burkitt Lymphoma 62 Lymphoma, Follicular 59 Lymphoma, Mantle-Cell 55 Lung Neoplasms 53 Lymphoma, Large-Cell, Immunoblastic 49 Leukemia, Lymphocytic, Chronic, B-Cell 45 Multiple Myeloma 35 Recurrence 34 Lymphoma, B-Cell, Marginal Zone 33 Neuroblastoma 27 Congenital Abnormalities 25 Carcinoma, Non-Small-Cell Lung 24 Myelodysplastic Syndromes 23 Brain Neoplasms 20 Sarcoma 19 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma, Large-Cell, Anaplastic 19 Lymphoma, B-Cell 19 Ovarian Neoplasms 18 Lymphoma, T-Cell, Peripheral 17 Lymphoma, Extranodal NK-T-Cell 17 Dendritic Cell Sarcoma, Interdigitating 17

Interventions

Topotecan 3 Gemcitabine 2 vinflunine 1 pembrolizumab 1 bemiparin 1 belotecan 1 apalutamide 1 Taxes 1 Sorafenib 1 Penfluridol 1 Pemetrexed 1 Paclitaxel 1 Nortriptyline 1 Nivolumab 1 Ipilimumab 1 Etoposide 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Arsenic Trioxide 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00826644 2021-08-09

COMBAT

Chonnam National University Hospital

Phase 3 Completed

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡